Completed PHASE2 INTERVENTIONAL 4-arm NCT03887754

Therapeutic Issues for Autism

Therapeutic Issues for Autism Spectrum Disorders: a Clinical Trial

Sponsor: Minia University

Interventions Non specific Multivitamin Risperidone hyperbaric oxygen therapy

Updated 4 times since 2019 Last updated: Mar 20, 2019 Started: Jan 31, 2016 Primary completion: Jan 31, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Autism Spectrum Disorder and is currently completed. Minia University leads this study, which shows 4 recorded versions since 2016 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Apr 2019 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Minia University

Data source: Minia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.